Lophius Biosciences
Developing products for the diagnosis of acute infectious and autoimmune diseases
Lophius Biosciences has raised €2.2M across 1 funding round from 3 investors, most recently a Early VC round in Mar 2017. Based in Regensburg, Germany; founded 2008; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€2.2M
€2,200,000
Funding rounds
1
Investors
3
distinct backers
Active since
2017-03
latest 2017-03
Funding by year
EUR raised per yearLophius Biosciences — funding by year — interactive chart.
Data table
| Lophius Biosciences — funding by year | |
|---|---|
| 2017 | €2.2M |
Signals
High confidenceRaise-next likelihood8
base rate 42% for Early VC
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2017-03-01 | Early VC | €2.2M | Bayern Kapital,VRD,Wolf Biotech | View deal → |
Investors
3Related news
Similar companies
same sector or country- Delivery Hero€7.1BGermany · E-commerce
- Enpal€4.6BGermany · Cleantech
- Auxmoney€3.5BGermany · Fintech
- Helsing€2.9BGermany · AI
- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
Global coverage: FundingData